Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 74,205 | 86,180 | 1,615,797 | 1,095,415 | 76,368 |
| Cost of Goods | 845 | 2,765 | 146,319 | 65,865 | N/A |
| Gross Profit | 73,360 | 83,415 | 1,469,478 | 1,029,550 | 76,368 |
| Operating Expenses | 661,370 | 768,485 | 636,729 | 609,664 | 373,348 |
| Operating Income | -587,165 | -684,305 | 833,068 | 420,751 | -296,980 |
| Other Income | 64,060 | 56,111 | -78,788 | 129,051 | -1,631 |
| Pre-tax Income | -523,105 | -628,194 | 754,280 | 549,802 | -298,611 |
| Income Tax | -1,145 | -13,077 | 238,443 | 21,218 | 54 |
| Net Income Continuous | -521,960 | -615,117 | 515,837 | 528,584 | -298,665 |
| Minority Interests | N/A | -56 | N/A | N/A | N/A |
| Net Income | $-521,960 | $-615,061 | $515,837 | $528,584 | $-298,665 |
| EPS Basic Total Ops | -3.83 | -4.59 | 3.89 | 4.07 | -2.51 |
| EPS Basic Continuous Ops | -3.83 | -4.59 | 3.89 | 4.07 | -2.51 |
| EPS Diluted Total Ops | -3.83 | -4.59 | 3.83 | 3.96 | -2.51 |
| EPS Diluted Continuous Ops | -3.83 | -4.59 | 3.83 | 3.96 | -2.51 |
| EPS Diluted Before Non-Recurring Items | -3.83 | -4.59 | 3.83 | 3.96 | -2.51 |
| EBITDA(a) | $-567,209 | $-673,560 | $830,908 | $426,318 | $-289,158 |